ID   GM05652
AC   CVCL_N039
SY   GM 5652; GM05652A; GM17313
DR   CLO; CLO_0013356
DR   CLO; CLO_0024593
DR   Coriell; GM05652
DR   Coriell; GM17313
DR   Wikidata; Q54841899
RX   CelloPub=CLPUB00447;
RX   PubMed=3926002;
CC   Part of: Human variation panel.
CC   Population: South American (Brazil, Guyana, Venezuela).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y6M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 14
//
RX   CelloPub=CLPUB00447;
RA   Mulivor R.A., Suchy S.F.;
RT   "1992/1993 catalog of cell lines. NIGMS human genetic mutant cell
RT   repository. 16th edition. October 1992.";
RL   (In) Institute for Medical Research (Camden, N.J.) NIH 92-2011; pp.1-918; National Institutes of Health; Bethesda (1992).
//
RX   PubMed=3926002; DOI=10.1016/0005-2760(85)90115-8;
RA   Kobayashi T., Shinnoh N., Goto I., Kuroiwa Y., Okawauchi M.,
RA   Sugihara G., Tanaka M.;
RT   "Galactosylceramide- and lactosylceramide-loading studies in cultured
RT   fibroblasts from normal individuals and patients with globoid cell
RT   leukodystrophy (Krabbe's disease) and GM1-gangliosidosis.";
RL   Biochim. Biophys. Acta 835:456-464(1985).
//